Zaleplon may increase the risk of injury among the elderly. It should not be used while in pregnancy or lactation, and in patients with a history of alcohol or drug abuse, psychotic illness or ...

Zaleplon may be administered at bedtime, later at night after difficulty falling asleep becomes evident, or upon awakening in the middle of the night.

Sleepwalking, sleep-driving, and sleep-using-a-stove are not things that you want to do. Therefore, the U.S. Food and Drug Administration on Tuesday announced that eszopiclone, zaleplon, and ...

Zaleplon (N-[3-(3-cyanopyrazolo[ 1,5-alpha]pyrimidin-7-yl)phenyl]-N- ethylacetamide) is a novel nonbenzodiazepine hypnotic that has agonist activity at the benzodiazepine type 1 receptor on the ...

Zaleplon tablets include treatment of competence sleeplessness. Zaleplon is also known in other sleep disorders in frequent disturbances in childhood. Transient impairment of lithium and psychomotor ...

Eszopiclone, zaleplon and zolpidem are insomnia medications that help patients fall asleep or stay asleep easier by slowing brain activity, the FDA said. The agency had warned of possible side ...

Certain commonly used sleeping pills will now contain a new boxed warning, the FDA announced Tuesday. The agency identified 66 reports of patients who died or were injured after taking these drugs.

4 Evidence and interpretation. The Appraisal Committee considered evidence from a number of sources (see Appendix B).The remit given to NICE by the Department of Health/Welsh Assembly Government was ...

PITTSBURGH The Food and Drug Administration has granted final approval for Mylan subsidiary Genpharm’s application for 5mg and 10mg Zaleplon Capsules, Mylan announced Monday. Zaleplon Capsules ...

4.3 Consideration of the evidence. 4.3.1 The Committee reviewed the evidence available on the clinical and cost effectiveness of zaleplon, zolpidem and zopiclone, having considered evidence on the ...